Cite
HARVARD Citation
Cannon, G. et al. (2016). Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis. Advances in therapy. 33 (8), pp. 1347-1359. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cannon, G. et al. (2016). Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis. Advances in therapy. 33 (8), pp. 1347-1359. [Online].